OTCMCNTMF
Market cap25mUSD
Jan 10, Last price
0.09USD
1D
-2.27%
1Q
-42.67%
IPO
-94.45%
Name
Cansortium Inc
Chart & Performance
P/E
—
P/S
0.26
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
31.12%
Rev. gr., 5y
64.56%
Revenues
97m
+10.95%
Net income
-23m
L-38.76%
CFO
18m
-3.22%
Earnings
May 28, 2025
Profile
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. The company engages in the cultivation, processing, retail, and distribution activities. Its medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls, cartridges, and edibles. The company provides its products under the Fluent brand name. As of August 20, 2021, it operated 28 dispensaries. Cansortium Inc. was incorporated in 2018 and is headquartered in Miami, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 97,290 10.95% | 87,692 34.01% | ||||||
Cost of revenue | 80,705 | 78,143 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 16,585 | 9,549 | ||||||
NOPBT Margin | 17.05% | 10.89% | ||||||
Operating Taxes | 13,594 | 10,376 | ||||||
Tax Rate | 81.97% | 108.66% | ||||||
NOPAT | 2,991 | (827) | ||||||
Net income | (22,750) -38.76% | (37,146) 95.46% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 2,992 | 4,795 | ||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 3,085 | 2,864 | ||||||
Long-term debt | 138,545 | 126,936 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | 3,882 | 1,333 | ||||||
Net debt | 131,109 | 121,441 | ||||||
| Cash flow | ||||||||
Cash from operating activities | 18,455 | 19,069 | ||||||
CAPEX | (6,019) | (6,799) | ||||||
Cash from investing activities | (6,338) | (6,774) | ||||||
Cash from financing activities | (9,955) | (13,048) | ||||||
FCF | (8,021) | 6,149 | ||||||
| Balance | ||||||||
Cash | 10,521 | 8,359 | ||||||
Long term investments | ||||||||
Excess cash | 5,656 | 3,974 | ||||||
Stockholders' equity | 8,585 | (14,451) | ||||||
Invested Capital | 108,326 | 123,147 | ||||||
ROIC | 2.58% | |||||||
ROCE | 12.62% | 7.40% | ||||||
| EV | ||||||||
Common stock shares outstanding | 292,622 | 252,699 | ||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 31,663 | 22,977 | ||||||
EV/EBITDA | ||||||||
Interest | 17,982 | 16,206 | ||||||
Interest/NOPBT | 108.42% | 169.71% | ||||||